| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 14D65TV20J |
| InChI Key | YUAALFPUEOYPNX-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H30ClN7O2S |
| Molecular Weight | 516.07 |
| AlogP | 3.61 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 93.7 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 35.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
CAMK protein kinase group
CAMK protein kinase CAMK1 family
CAMK protein kinase CHK1 subfamily
|
- | - | - | - | 50 | |
|
Enzyme
Kinase
Protein Kinase
Other protein kinase group
Other protein kinase AUR family
|
- | 12 | - | - | 50 | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Axl family
|
222-305 | 27 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2022968 |
| DrugBank | DB15187 |
| FDA SRS | 14D65TV20J |
| Guide to Pharmacology | 8863 |
| PubChem | 56839178 |
| SureChEMBL | SCHEMBL12813478 |
| ZINC | ZINC000084617535 |